Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
We propose a label free, non-invasive and efficient immunosensing platform to investigate an oral cancer biomarker
(CYFRA-21-1) that is secreted in saliva sample. For the fabrication of this immunosensor, Yttrium Oxide (Y2O3) was
used as an interfacing material synthesized through hydrothermal process. Further, 3-aminopropyl triethoxy silane (APTES)
was used to functionalize Y2O3 nanoparticles. Electrophoretic deposition technique was used to deposit functionalized Y2O3
(i.e., APTES/Y2O3) on indium tin oxide coated glass (ITO) electrode at 50 V for 60 sec. For efficient covalent immobilization
of anti-CYFRA-21-1 on APTES/Y2O3/ITO, EDC/NHS chemistry was utilized. Synthesized nanostructured Y2O3 and
immunoelectrode was characterized by X-ray diffraction (XRD), atomic force microscopy (AFM), fourier transform infrared
spectroscopy (FT-IR), scanning electron microscopy (SEM) and cyclic voltammetry (CV) techniques. The electrochemical
response studies reveal that the immunosensor can be used to estimate CYFRA-21-1 biomarker in a wide linear detection
range (2 to 22 ng mL-1), has high sensitivity (9.8Ã?Â?10-3 mA mL ng-1 cm-2) and remarkable lower detection limit (0.218 ng mL-
1) with shelf life of up to 7 weeks. The results of these studies have been validated via enzyme linked immunosorbent assay
(ELISA). The results of these studies reveal the efficacy of the BSA/anti-CYFRA-21-1/APTES/Y2O3/ITO platform as a high
throughput compact biosensing device for investigating CYFRA-21-1 biomolecules.